Royalty Pharma Overview

  • Investor Type
  • PE/​Buyout

  • Status
  • Active

  • Professionals
  • 11

Professionals

  • Investments
  • 48

  • Portfolio
  • 9

  • Exits
  • 5

Exits

Royalty Pharma General Information

Company Description

Founded in 1996, Royalty Pharma is a private equity firm based in New York, New York. The firm seeks to invest in healthcare and life sciences sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Website
www.royaltypharma.com
Year Founded
1996
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Corporate Office
  • 110 East 59th Street
  • Suite 3300
  • New York, NY 10022
  • United States
+1 (212)

Royalty Pharma Investments & Acquisitions (48)

Royalty Pharma’s most recent investment was a with RP Management (New York) for . The deal was made on 10-Jan-2025 with as the lead partner.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
RP Management (New York) 10-Jan-2025 Other Financial Services Generating Revenue
Elektrofi 08-Aug-2024 Drug Delivery Generating Revenue
Agios Pharmaceuticals (15% Royalty Vorasidenib) 06-Aug-2024 Buildings and Property
ImmuNext (Royalty Interest in Frexalimab) 09-May-2024 Buildings and Property
Adstiladrin (Royalty Rights) 24-Aug-2023 Secondary Transaction - Private Buildings and Property
You’re viewing 5 of 48 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Royalty Pharma Exits (5)

Royalty Pharma has made a total of 5 exits. Its latest exit was from Epizyme for on 12-Aug-2022. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Epizyme 12-Aug-2022
Biohaven 20-Jun-2019
Nektar Therapeutics 23-Jan-2014
Sunesis 31-Dec-2013
Cypress Bioscience 01-Aug-2011 Out of Business
To view Royalty Pharma’s complete exits history, request access »

Royalty Pharma Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Royalty Pharma Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
RPI 2019 Intermediate Finance Trust New York, NY 2019
RPI Intermediate Finance Trust New York, NY 2019
Erleada Titusville, NJ
Orkambi Boston, MA

Royalty Pharma FAQs

  • What is Royalty Pharma?

    Founded in 1996, Royalty Pharma is a private equity firm based in New York, New York.

  • When was Royalty Pharma founded?

    Royalty Pharma was founded in 1996.

  • Where is Royalty Pharma headquartered?

    Royalty Pharma is headquartered in New York, NY.

  • What is Royalty Pharma's total asset value?

    Royalty Pharma has around in total assets under management.

  • How many investments has Royalty Pharma made?

    Royalty Pharma has made 48 investments.

  • What has Royalty Pharma invested in?

    Royalty Pharma has made numerous investments in companies like RP Management (New York), Elektrofi, and Agios Pharmaceuticals (15% Royalty Vorasidenib) within the Financial Services, Drug Delivery, and Buildings and Property industries.

  • What has Royalty Pharma invested in recently?

    Royalty Pharma's latest investment was on 10-Jan-2025 in RP Management (New York), a company within the Financial Services industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »